- Investing Ideas
- Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
6
Companies with a Value score of at least 3, ordered by Value score
6 companies
Gilead Sciences
Market Cap: CL$183.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDCL
CL$127,000.00
7D
4.2%
1Y
60.8%
Gilead Sciences
Market Cap: US$183.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$138.92
7D
4.4%
1Y
25.8%
Amgen
Market Cap: CL$239.2b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGNCL
CL$383,390.00
7D
0.3%
1Y
30.7%
Biogen
Market Cap: CL$32.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBCL
CL$191,200.00
7D
0.7%
1Y
35.7%
Biogen
Market Cap: US$32.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$209.15
7D
1.0%
1Y
60.6%
Amgen
Market Cap: US$239.2b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$419.38
7D
0.5%
1Y
64.4%